82 results
Keyword Eklira Genuair Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Eklira Genuair
aclidinium bromide, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 20/07/2012,
, Revision: 20, Authorised, Last updated: 11/01/2023
Eklira Genuair Respiratory Tract Diseases Lung … Eklira Genuair … Eklira Genuair, INN-aclidinium bromide … -
List item
Human medicine European public assessment report (EPAR): Duaklir Genuair
aclidinium bromide, formoterol fumarate dihydrate, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 19/11/2014,, Revision: 15, Authorised, Last updated: 11/01/2023
Duaklir Genuair Respiratory Tract Diseases Lung … report (EPAR) for Duaklir Genuair. It explains how the Agency … advice on how to use Duaklir Genuair. For practical information … -
List item
Human medicine European public assessment report (EPAR): Bretaris Genuair
aclidinium bromide, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 20/07/2012,, Revision: 18, Authorised, Last updated: 05/01/2023
Bretaris Genuair Respiratory Tract Diseases Lung … report (EPAR) for Bretaris Genuair. It explains how the Agency … advice on how to use Bretaris Genuair. For practical information … -
List item
Human medicine European public assessment report (EPAR): Brimica Genuair
formoterol fumarate dihydrate, aclidinium bromide, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 19/11/2014,, Revision: 13, Authorised, Last updated: 04/01/2023
Brimica Genuair Respiratory Tract Diseases Lung … report (EPAR) for Brimica Genuair. It explains how the Agency … advice on how to use Brimica Genuair. For practical information … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 May 2012
CHMP, Last updated: 25/05/2012Bretaris Genuair Eklira Genuair … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 September 2014
CHMP, Last updated: 26/09/2014Brimica Genuair … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 February 2023 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 06/02/2023 to 09/02/2023, Last updated: 17/05/2023 -
List item
List of medicines under additional monitoring (updated)
Last updated: 30/05/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 10-13 January 2022
European Medicines Agency, Amsterdam, the Netherlands, from 10/01/2022 to 13/01/2022, Last updated: 07/10/2022 -
List item
PRAC: Agendas, minutes and highlights (updated)
Last updated: 07/06/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 February 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/02/2022 to 10/02/2022, Last updated: 07/11/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 February 2014
European Medicines Agency, London, UK, from 03/02/2014 to 06/02/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 September 2014
European Medicines Agency, London, UK, from 08/09/2014 to 11/09/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 10-13 June 2014
European Medicines Agency, London, UK, from 10/06/2014 to 13/06/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 26-29 November 2012
European Medicines Agency, London, UK, from 26/11/2012 to 29/11/2012, Last updated: 26/11/2012 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 February 2018
European Medicines Agency, London, UK, from 05/02/2018 to 08/02/2018, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 2-5 September 2013
European Medicines Agency, London, UK, from 02/09/2013 to 05/09/2013, Last updated: 02/07/2012 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 April 2013
European Medicines Agency, London, UK, from 08/04/2013 to 11/04/2013, Last updated: 02/06/2012 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 29-31 October 2012
European Medicines Agency, London, UK, from 29/10/2012 to 31/10/2012, Last updated: 03/12/2012 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 July 2020
European Medicines Agency, Amsterdam, the Netherlands, from 06/07/2020 to 09/07/2020, Last updated: 10/12/2020 -
List item
PRAC: meeting archive 2012-2014
Last updated: 13/05/2016 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 26-29 October 2020
Virtual meeting, from 26/10/2020 to 29/10/2020, Last updated: 08/01/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 August – 2 September 2021
PRAC, Last updated: 17/09/2021 -
List item
PRAC: Committee agendas, minutes and meeting highlights report archive 2012-2013
Last updated: 01/01/2015 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 February 2021
European Medicines Agency, Amsterdam, the Netherlands, from 08/02/2021 to 11/02/2021, Last updated: 08/02/2021